How do I read and understand my Melanoma pathology report

MelanomaMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Your Melanoma Pathology Report

A pathology report is one of the most important documents you'll receive after a skin biopsy. It describes what the pathologist (a doctor who examines tissue under a microscope) found in your sample. Let me walk you through what these reports typically contain and what the key findings mean.

The Main Sections of Your Report

1. Clinical History/Reason for Biopsy

This section describes what your doctor sent to the lab. It might say something like "pigmented lesion on left shoulder" or "changing mole." This helps the pathologist understand the context.

2. Specimen Description

This describes the physical sample—its size, color, and appearance. For example: "tan-brown tissue measuring 8mm in greatest dimension."

3. Microscopic Findings (The Most Important Part)

This is where the pathologist describes what they saw under the microscope. Key findings include:

Is it melanoma?

  • Benign (non-cancerous): The lesion is not cancer. Examples include common moles or other skin growths.
  • Melanoma: Cancer cells are present. This is the diagnosis that requires treatment.
  • Atypical/Dysplastic nevus: An abnormal mole that's not quite cancer but has concerning features. These need close monitoring.

4. Breslow Thickness (If Melanoma is Present)

According to the NCCN Guidelines for Patients: Melanoma, this is one of the most critical measurements. Breslow thickness measures how deep the melanoma has grown into your skin, measured in millimeters (mm).

What it means:

  • Less than 1.0 mm: Thin melanoma (generally earlier stage, better prognosis)
  • 1.0-2.0 mm: Intermediate thickness
  • 2.0-4.0 mm: Thicker melanoma
  • Greater than 4.0 mm: Very thick melanoma (more advanced)

The deeper the melanoma grows, the higher the stage and the more likely it may have spread to lymph nodes or other areas.

5. Ulceration

This describes whether the skin surface over the melanoma is broken or eroded. Ulceration (an open sore) is an important prognostic factor—it suggests the melanoma may be more aggressive.

6. Mitotic Rate

This measures how many cancer cells are actively dividing (growing). It's reported as the number of dividing cells per square millimeter. A higher mitotic rate generally indicates more aggressive cancer.

7. Clark Level (Sometimes Included)

This describes which layer of skin the melanoma has invaded:

  • Level I: Only in the epidermis (top layer)
  • Level II-V: Progressively deeper into the dermis and beyond

8. Margins

This tells you whether the melanoma was completely removed with clear borders, or if cancer cells were found at the edge of the sample.

  • Clear/Negative margins: Good—all visible cancer was removed
  • Involved/Positive margins: Cancer cells reached the edge, meaning more tissue may need to be removed

9. Lymphovascular Invasion

This describes whether cancer cells were found in blood vessels or lymph vessels in the skin. If present, it suggests the cancer may have a higher risk of spreading.

10. BRAF Mutation Status (If Tested)

According to NCCN Guidelines, some pathology reports include testing for BRAF mutations. BRAF mutations are genetic changes found in some melanomas. If your melanoma has a BRAF V600 mutation, this opens up targeted therapy options that your oncologist may consider.

What Happens After You Get Your Report

According to the NCCN Guidelines for Patients: Melanoma, after the initial biopsy, you'll typically have:

  1. Staging after surgery: Your doctor will likely recommend surgery to remove more skin around the biopsy site to ensure clear margins. After that surgery, you may receive additional staging tests (like imaging or sentinel lymph node biopsy) depending on your Breslow thickness and other risk factors.

  2. Treatment decisions: Your stage and the features in your pathology report will guide treatment recommendations, which may include:

    • Observation (for very early stages)
    • Immunotherapy (like nivolumab or pembrolizumab)
    • Targeted therapy (if BRAF mutation is present)
    • Radiation therapy
    • Other systemic treatments

Questions to Ask Your Doctor About Your Pathology Report

  1. Is this melanoma, and if so, what stage is it?
  2. What is the Breslow thickness, and what does that mean for my treatment?
  3. Were the margins clear, or do I need additional surgery?
  4. Was my melanoma tested for BRAF mutations, and what were the results?
  5. Based on these findings, what treatment options do you recommend for me?
  6. Do I need a sentinel lymph node biopsy or other staging tests?
  7. What is my follow-up plan, and how often will I need skin exams?

Important Context

Your pathology report is one piece of information your oncologist uses to make treatment decisions. They'll also consider your overall health, the location of the melanoma, and other factors. The good news, according to NCCN Guidelines, is that melanoma is curable, especially if caught early—more than 3 in 4 melanomas are found before they've spread.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: